BarH-like homeobox 2 represses the transcription of keratin 16 and affects Ras signaling pathway to suppress nasopharyngeal carcinoma progression

References

• Chen YP, Chan ATC, Le QT, et al. Nasopharyngeal carcinoma. Lancet. 2019;394(10192):64–80.
   PubMed Web of Science ®Google Scholar
• Lee HM, Okuda KS, Gonzalez FE, et al. Current Perspectives on Nasopharyngeal Carcinoma. Adv Exp Med Biol. 2019;1164:11–34.
   PubMed Web of Science ®Google Scholar
• Han B, Yang X, Zhang P, et al. DNA methylation biomarkers for nasopharyngeal carcinoma. PLoS One. 2020;15(4):e0230524.
   PubMed Web of Science ®Google Scholar
• Herring BP, Kriegel AM, Hoggatt AM. Identification of Barx2b, a serum response factor-associated homeodomain protein. J Biol Chem. 2001;276(17):14482–14489.
   PubMed Web of Science ®Google Scholar
• Meech R, Edelman DB, Jones FS, et al. The homeobox transcription factor Barx2 regulates chondrogenesis during limb development. Development. 2005;132(9):2135–2146.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang JX, Huang LL, et al. Low expression of BARX2 in human primary hepatocellular carcinoma correlates with metastasis and predicts poor prognosis. Hepatol Res. 2015;45(2):228–237.
   PubMed Web of Science ®Google Scholar
• Chen H, Zhang M, Zhang W, et al. Downregulation of BarH-like homeobox 2 promotes cell proliferation, migration and aerobic glycolysis through Wnt/beta-catenin signaling, and predicts a poor prognosis in non-small cell lung carcinoma. Thorac Cancer. 2018;9(3):390–399.
   PubMed Web of Science ®Google Scholar
• Stevens TA, Meech R. BARX2 and estrogen receptor-alpha (ESR1) coordinately regulate the production of alternatively spliced ESR1 isoforms and control breast cancer cell growth and invasion. Oncogene. 2006;25(39):5426–5435.
   PubMed Web of Science ®Google Scholar
• Karantza V. Keratins in health and cancer: more than mere epithelial cell markers. Oncogene. 2011;30(2):127–138.
   PubMed Web of Science ®Google Scholar
• Joosse SA, Hannemann J, Spotter J, et al. Changes in keratin expression during metastatic progression of breast cancer: impact on the detection of circulating tumor cells. Clin Cancer Res. 2012;18(4):993–1003.
   PubMed Web of Science ®Google Scholar
• Yuanhua L, Pudong Q, Wei Z, et al. TFAP2A Induced KRT16 as an oncogene in lung adenocarcinoma via EMT. Int J Biol Sci. 2019;15(7):1419–1428.
   PubMed Web of Science ®Google Scholar
• Degirmenci U, Wang M, Hu J. Targeting aberrant RAS/RAF/MEK/ERK signaling for cancer therapy. Cells. 2020;9(1):198.
   PubMed Web of Science ®Google Scholar
• Chen JG, Fan HY, Wang T, et al. Silencing KRT16 inhibits keratinocyte proliferation and VEGF secretion in psoriasis via inhibition of ERK signaling pathway. Kaohsiung J Med Sci. 2019;35(5):284–296.
   PubMed Web of Science ®Google Scholar
• Jiang N, Zhao L, Zong D, et al. Long non-coding RNA LUADT1 promotes nasopharyngeal carcinoma cell proliferation and invasion by downregulating miR-1207-5p. Bioengineered. 2021;12(2):10716–10728.
   PubMed Web of Science ®Google Scholar
• Liu F, Wei J, Hao Y, et al. Long intergenic non-protein coding RNA 02570 promotes nasopharyngeal carcinoma progression by adsorbing microRNA miR-4649-3p thereby upregulating both sterol regulatory element binding protein 1, and fatty acid synthase. Bioengineered. 2021;12(1):7119–7130.
   PubMed Web of Science ®Google Scholar
• Zhang M, Xu Y, Yin S, et al. YY1-induced long non-coding RNA PSMA3 antisense RNA 1 functions as a competing endogenous RNA for microRNA 214-5p to expedite the viability and restrict the apoptosis of bladder cancer cells via regulating programmed cell death-ligand 1. Bioengineered. 2021;12(2):9150–9161.
   PubMed Web of Science ®Google Scholar
• Le QT, Colevas AD, O’Sullivan B, et al. Current treatment landscape of nasopharyngeal carcinoma and potential trials evaluating the value of immunotherapy. J Natl Cancer Inst. 2019;111(7):655–663.
   PubMedGoogle Scholar
• Cao SM, Simons MJ, Qian CN. The prevalence and prevention of nasopharyngeal carcinoma in China. Chin J Cancer. 2011;30(2):114–119.
   PubMedGoogle Scholar
• Jones FS, Kioussi C, Copertino DW, et al. Barx2, a new homeobox gene of the Bar class, is expressed in neural and craniofacial structures during development. Proc Natl Acad Sci U S A. 1997;94(6):2632–2637.
   PubMed Web of Science ®Google Scholar
• Mi Y, Zhao S, Zhang W, et al. Down-regulation of Barx2 predicts poor survival in colorectal cancer. Biochem Biophys Res Commun. 2016;478(1):67–73.
   PubMed Web of Science ®Google Scholar
• Lin SC, Kao SY, Chang JC, et al. Up-regulation of miR-187 modulates the advances of oral carcinoma by targeting BARX2 tumor suppressor. Oncotarget. 2016;7(38):61355–61365.
   PubMedGoogle Scholar
• Ma J, Xia LL, Yao XQ, et al. BARX2 expression is downregulated by CpG Island hypermethylation and is associated with suppressed cell proliferation and invasion of gastric cancer cells. Oncol Rep. 2020;43(6):1805–1818.
   PubMed Web of Science ®Google Scholar
• Yang F, Shao C, Wei K, et al. miR-942 promotes tumor migration, invasion, and angiogenesis by regulating EMT via BARX2 in non-small-cell lung cancer. J Cell Physiol. 2019;234(12):23596–23607.
   PubMed Web of Science ®Google Scholar
• Meech R, Makarenkova H, Edelman DB, et al. The homeodomain protein Barx2 promotes myogenic differentiation and is regulated by myogenic regulatory factors. J Biol Chem. 2003;278(10):8269–8278.
   PubMed Web of Science ®Google Scholar
• Sellar GC, Li L, Watt KP, et al. BARX2 induces cadherin 6 expression and is a functional suppressor of ovarian cancer progression. Cancer Res. 2001;61(19):6977–6981.
   PubMed Web of Science ®Google Scholar
• Maruthappu T, Chikh A, Fell B, et al. Rhomboid family member 2 regulates cytoskeletal stress-associated Keratin 16. Nat Commun. 2017;8(1):14174.
   PubMedGoogle Scholar
• Endo H, Sugioka Y, Nakagi Y, et al. A novel role of the NRF2 transcription factor in the regulation of arsenite-mediated keratin 16 gene expression in human keratinocytes. Environ Health Perspect. 2008;116(7):873–879.
   PubMed Web of Science ®Google Scholar
• Huang WC, Jang TH, Tung SL, et al. A novel miR-365-3p/EHF/keratin 16 axis promotes oral squamous cell carcinoma metastasis, cancer stemness and drug resistance via enhancing beta5-integrin/c-met signaling pathway. J Exp Clin Cancer Res. 2019;38(1):89.
   PubMedGoogle Scholar
• Santarpia L, Lippman SM, El-Naggar AK. Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy. Expert Opin Ther Targets. 2012;16(1):103–119.
   PubMed Web of Science ®Google Scholar
• Yang CY, Wang J, Zhang JQ, et al. Human circular RNA hsa_circRNA_101705 (circTXNDC11) regulates renal cancer progression by regulating MAPK/ERK pathway. Bioengineered. 2021;12(1):4432–4441.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Hu Q, Li H. Isoprenylcysteine carboxylmethyltransferase is associated with nasopharyngeal carcinoma chemoresistance and Ras activation. Biochem Biophys Res Commun. 2019;516(3):784–789.
   PubMed Web of Science ®Google Scholar